Results Show No Significant Differences Between Needle-Free and Syringe Delivery of Insulin Lispro
Read More »Free Style Connect System
FreeStyle Connect System. Abbott Laboratories Inc. last Monday said U.S. regulators approved its for monitoring levels of blood glucose, for use in hospitals and medical clinics. The U.S. Food and Drug Administration approved the device following a series of clinical trials in which the device provided reliable glucose readings within …
Read More »Stress Does Not Effect Blood Sugars During Fasting
For type 1 diabetes patients, a episode of psychological stress significantly slows the decline in blood sugar concentrations following a spike after food intake — but has no effect on sugar levels during fasting — a new study shows.
Read More »Life-extending Protein Keeps Blood Sugar in Control
A protein that extends lifespan in yeast, worms, and flies keeps blood sugar under control in mice.
Read More »Metformin Added to Insulin in Pediatric Type 1 Patients
Metformin is safe and may represent a useful adjunct to the management of type 1 diabetes mellitus in adolescents and young adults.
Read More »Increasing Sugar Processing in The Liver Can Lower Blood Sugar
Researchers have shown that increasing the concentration of a key regulator involved in glucose metabolism can improve the way the liver produces and disposes of the sugar glucose.
Read More »Non-invasive Imaging Helps to Predict Type 1 Diabetes and Response to Treatment
Physicians may be able to identify individuals with preclinical type 1 diabetes, and to assess the effectiveness of therapies.
Read More »Insulin Resistance Detectable 20 Years Before Type 2 Diabetes Onset
New Research now provides new information on the early steps in the development of IR and suggests why insulin-resistant people easily gain weight.
Read More »Hormone Linked to Sugar Control in Diabetics
High blood levels of a hormone called adiponectin are associated with improved sugar
Read More »U.S. FDA Refuses to Pull Abbott Obesity Drug Merida
The U.S. Food and Drug Administration rejected a consumer group’s petition to withdraw Abbott Laboratories Inc.’s obesity drug Meridia (sibutramine).
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.